ФАРМАЦЕВТИЧЕСКАЯ ЛЕКАРСТВЕННАЯ ФОРМА, УСТОЙЧИВАЯ К ДЕЙСТВИЮ ЖЕЛУДОЧНОГО СОКА, ВКЛЮЧАЮЩАЯ N-(-ФТАЛИМИДОЭТОКСИ)АЦЕТИЛ)-L-АЛАНИЛ-D-ГЛУТАМИНОВУЮ КИСЛОТУ (LK 423)

摘要

The present invention relates to the pharmaceutical dosage forms which enable a controlled and/or a targeted delivery of an active substance to the selected regions of gastrointestinal tract of humans or animals. The pharmaceutical dosage forms preferably comprises the active substance N-(2(2-phthalimidoethoxy)-acetyl)-L-alanyl-D-glutamic acid (designated as LK 423). Methods of treatment of chronic inflammatory diseases of gastrointestinal tract of humans and/or animals by using the pharmaceutical dosage forms of the invention are disclosed.